AnaptysBio Inc ANAB.O:
ANAPTYS ANNOUNCES $100 MILLION STOCK REPURCHASE PLAN AND PROVIDES A BUSINESS UPDATE
ANAPTYSBIO INC - TO SPIN-OFF BIOPHARMA OPERATIONS INTO FIRST TRACKS BIOTHERAPEUTICS ON APRIL 20, 2026
ANAPTYSBIO INC: DANIEL FAGA WILL CONTINUE AS CEO OF ANAPTYS POST THE SPIN-OFF OF FIRST TRACKS BIO
ANAPTYSBIO INC: POST SPIN-OFF ANTICIPATE PAYDOWN OF REMAINING NON-RECOURSE DEBT MONETIZATION TO SAGARD BY THE END OF Q2 2027
ANAPTYSBIO INC: SEARCH INITIATED FOR A CFO FOR ANAPTYS POST THE SPIN-OFF OF FIRST TRACKS BIO
Source text: ID:nGNXbNzcwH
Further company coverage: ANAB.O